Form-Fill-Protect-Comply With Pharmaguard®

The pharmaceutical industry is in a transformation-phase, trying to move from linear to circular economy models. PharmaGuard is recognized as one of the leading polyolefin blister packaging solution, and recently has been rewarded with the ‘Prestigious German Packaging Award’ (Deutscher Verpackungspreis) in the sustainability category. After its launch early 2023, PharmaGuard has gained lots of market interest, and is recognized as the leading recycle ready solution for the future. With its excellent transparency, good and stable shrinkage behavior, and a wider thermoforming- and sealing window, together with its controllable push-through lidding, PharmaGuard is setting new industry standards. You will learn more about: PharmaGuards’ different segment specific solutions, e.g. for applications with higher barrier demands. The environment footprint of different solutions. How the pharma industry can significantly reduce carbon emissions in a safe and efficient way.

Keynote Speaker: The importance of embedding sustainability within your overall organizational strategy Companies need to understand the long-term value of sustainability, not only to ensure a positive impact on society and the environment, but also to grow their businesses

Plastic solutions in healthcare are vital. Though carbon emissions and wastefulness are inherent in today’s linear economy, changes are needed across the pharma and healthcare industry. To manage this in a safe way, strong value-chain collaboration is needed.
Key talking points include:
Assessing Borealis Bornewables™ and Borcycle™ C solutions in existing polypropylene medical grades Bormed™ Analysing how SÜDPACK PharmaGuard™ can be a great mono-PP solution for blisters and why it can help the pharma industry to materialize significant reduction in carbon emissions more efficiently. Reviewing case studies in recycled and renewable feedstock and why there are no changes needed in current regulations

With a science-based target set for 2030, Merck has launched a Supplier Decarbonization Program to lower the greenhouse gas emissions along its supply chain. Creating transparency of the emissions associated with the products Merck purchases is key to understanding how this reduction is progressing. Companies can demonstrate reductions of this typically large share of their emissions profile by collecting product carbon footprints (PCF) from their suppliers.
Whereas many companies have begun to assess their GHG emissions, few are at the stage of routinely calculating PCFs according to standardized methodologies. The PCF Guideline developed by Together for Sustainability addresses this challenge for molecules used in the chemical, pharmaceutical and other industries and provides tailored instructions on how to perform these calculations in compliance with existing guidelines like ISO or GHG protocol. This collaborative publication moves corporations towards exchanging harmonized and reliable data that support tangible GHG emission reductions

Ferrar’s objective is to lead change towards more sustainable production by adopting criteria and commitments that minimize the environmental footprint of its containers and packaging
For this, it has designed the Sustainable Packaging Model, with the participation of Anthesis Lavola.
The Model has 4 strategic axes and each one has specific and monitorable objectives to achieve them: Design for Good Natural resources protection Zero Waste loop and Collaboration In this case study session, Ferrer and Anthesis Lavola will deep-dive into the Sustainable Packaging Model, an initiative that can serve as inspiration for those looking to progress towards packaging circularity

The complexity and risks found within the global pharma supply chain cannot be understated and key stakeholders from customers to regulators, and investors are increasingly expecting the industry to both manage ESG risks and embed sustainability throughout the value chain.
This can only be achieved through industry-wide collaboration that establishes shared frameworks for what a responsible supply chain looks like. The Pharmaceutical Supply Chain Initiative (PSCI) and our membership of 70+ pharma and healthcare companies are leading this collaboration.
Through our Shared Audit Program, we are putting ESG into practice and building responsible supply chains.

Join the discussion with our thought leaders from across pharma to discuss what’s next for the sector in terms of sustainability and the logistics of creating a circular economy.
Building a circular economy through collaboration
Setting targets and defining your sustainability strategy
Sharing current practices in packaging, process chemicals, and manufacturing to improve other sectors"

For the past 20 years in healthcare, Polypropylene (PP) has been the most utilized plastic across a range of applications, from high-risk applications such as IV parenteral packaging to medical devices and diagnostics. PP offers alternatives to glass, metal and other plastics, such as PS or PVC. The pressure to find more environmentally friendly packaging solutions has increased significantly. SÜDPACK Medica’s Ecoterm™ Pharma PP pushes thermoforming of PP systems to a new level in terms of barrier level and shrinkage control. The change from PVC now becomes much easier. Halogen-free alternatives are a key consideration for making these sustainable decisions. Our expert speaker will talk about the ideal blister packaging and the reason why PP is the recommended material for oral solid dose packaging. You will hear more about PP as a polymer, advantages, focus areas, and recent LCA studies including the topic of sustainability.